Endogenous Galectin-1 in T Lymphocytes Regulates Anti-prostate Cancer Immunity

about

Endogenous Galectin-1 in T Lymphocytes Regulates Anti-prostate Cancer Immunity

Item

http://www.wikidata.org/entity/Q57491420

description

wetenschappelijk artikel

@nl

наукова стаття, опублікована у 2018

@uk

name

Endogenous Galectin-1 in T Lymphocytes Regulates Anti-prostate Cancer Immunity

@en

Endogenous Galectin-1 in T Lymphocytes Regulates Anti-prostate Cancer Immunity

@nl

type

Item

label

Endogenous Galectin-1 in T Lymphocytes Regulates Anti-prostate Cancer Immunity

@en

Endogenous Galectin-1 in T Lymphocytes Regulates Anti-prostate Cancer Immunity

@nl

prefLabel

Endogenous Galectin-1 in T Lymphocytes Regulates Anti-prostate Cancer Immunity

@en

Endogenous Galectin-1 in T Lymphocytes Regulates Anti-prostate Cancer Immunity

@nl

P1476

Endogenous Galectin-1 in T Lymphocytes Regulates Anti-prostate Cancer Immunity

@en

P2093

Daniel Compagno

http://www.w3.org/2001/XMLSchema#string

Diego Laderach

http://www.w3.org/2001/XMLSchema#string

Enrique Corapi

http://www.w3.org/2001/XMLSchema#string

Gustavo Carrizo

http://www.w3.org/2001/XMLSchema#string

P2860

Sipuleucel-T: APC 8015, APC-8015, prostate cancer vaccine--Dendreon

Analysis of protein profiles in human epithelial ovarian cancer tissues by proteomic technology.

Tumour antigens recognized by T lymphocytes: at the core of cancer immunotherapy.

Tolerogenic signals delivered by dendritic cells to T cells through a galectin-1-driven immunoregulatory circuit involving interleukin 27 and interleukin 10.

Tumor galectin-1 mediates tumor growth and metastasis through regulation of T-cell apoptosis

Galectin-1 is essential in tumor angiogenesis and is a target for antiangiogenesis therapy

Reprogramming the tumor microenvironment: tumor-induced immunosuppressive factors paralyze T cells.

The AP1-dependent secretion of galectin-1 by Reed Sternberg cells fosters immune privilege in classical Hodgkin lymphoma.

The involvement of Galectins in the modulation of the JAK/STAT pathway in myeloproliferative neoplasia

Clinical implication of the serum galectin-1 expression in epithelial ovarian cancer patients.

P304

2190

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.3389/FIMMU.2018.02190

http://www.w3.org/2001/XMLSchema#string

P407

English

P478

http://www.w3.org/2001/XMLSchema#string

P577

2018-01-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

30319642

http://www.w3.org/2001/XMLSchema#string

P932

6169479

http://www.w3.org/2001/XMLSchema#string